Other Events ·
InfuSystem postpones Q3 earnings release to evaluate $4.2M ERP cost capitalization
INFUInfuSystem Holdings, Inc
InfuSystem Holdings postponed its third quarter financial results originally scheduled for November 3, 2026, citing the need for additional time to complete its reporting process. The delay stems from an evaluation by management and its Audit Committee regarding whether $4.2 million in implementation costs for a new ERP system should be capitalized rather than expensed as incurred. These costs were accrued between July 1, 2024, and March 1, 2026. Any accounting adjustment would be non-cash and would not impact revenue or cash balances. The company expects to announce a revised release date soon. InfuSystem Holdings operates in the healthcare services industry, providing outpatient care and durable medical equipment support.